Updates on Imaging of Liver Tumors

Overview

Journal Curr Oncol Rep

Publisher Current Science

Specialty Oncology

Date 2020 Apr 17

PMID 32296952

Citations 7

Authors

Arya Haj-Mirzaian

Ana Kadivar

Ihab R Kamel

Atif Zaheer

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: We review advances in imaging of liver tumors, by particularly focusing on the utility of novel imaging in diagnosis and management of these lesions.

Recent Findings: Contrast-enhanced CT and/or MRI are currently utilized for accurate diagnosis of liver tumors, but several ongoing studies are examining the use of other advanced techniques. Novel CT (i.e., dual-energy CT and perfusion CT), MRI (diffusion-weighted imaging, MR elastography, and T1 mapping), and image processing (texture analysis and artificial intelligence-based methods) techniques have emerged and can be used for precise characterization of liver tumors, quantification of treatment responses, and prediction of overall survival rate of patients. Recent advancements in imaging of liver tumors allowed for a precise assessment of tumor features. These evolving technologies can be utilized for applying individualized treatment based on the presence of specific imaging biomarkers.

Citing Articles

Impact of MRI Texture Analysis on Complication Rate in MRI-Guided Liver Biopsies.

Leonhardi J, Niebur M, Hohn A, Ebel S, Struck M, Tautenhahn H J Imaging Inform Med. 2025; .

PMID: 39934533 DOI: 10.1007/s10278-025-01439-0.

Computed tomography image quality in patients with primary hepatocellular carcinoma: intraindividual comparison of contrast agent concentrations.

Peng F, Luo C, Ning X, Xiao F, Guan K, Tang C Front Med (Lausanne). 2024; 11:1460505.

PMID: 39478815 PMC: 11521877. DOI: 10.3389/fmed.2024.1460505.

Impact of CT texture analysis on complication rate in CT-guided liver biopsies.

Niebur M, Leonhardi J, Hohn A, Struck M, Ebel S, Prasse G Clin Exp Hepatol. 2024; 10(1):72-78.

PMID: 38765907 PMC: 11100340. DOI: 10.5114/ceh.2024.134141.

Imaging of pediatric liver tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.

Schooler G, Infante J, Acord M, Alazraki A, Chavhan G, Davis J Pediatr Blood Cancer. 2022; 70 Suppl 4:e29965.

PMID: 36102690 PMC: 10641897. DOI: 10.1002/pbc.29965.

Comparison of multiphase data from CT perfusion vs clinical 4-phase CT scans with respect to image quality, lesion detection, and LI-RADS classification in HCC patients.

Mohammadi A, Bartholmae W, Woisetschlager M Heliyon. 2022; 8(1):e08757.

PMID: 35146150 PMC: 8819526. DOI: 10.1016/j.heliyon.2022.e08757.

References

Mahmood U, Horvat N, Horvat J, Ryan D, Gao Y, Carollo G . Rapid switching kVp dual energy CT: Value of reconstructed dual energy CT images and organ dose assessment in multiphasic liver CT exams. Eur J Radiol. 2018; 102:102-108. PMC: 5918634. DOI: 10.1016/j.ejrad.2018.02.022. View

Borgheresi A, Gonzalez-Aguirre A, Brown K, Getrajdman G, Erinjeri J, Covey A . Does Enhancement or Perfusion on Preprocedure CT Predict Outcomes After Embolization of Hepatocellular Carcinoma?. Acad Radiol. 2018; 25(12):1588-1594. PMC: 6160360. DOI: 10.1016/j.acra.2018.02.027. View

Yasaka K, Akai H, Kunimatsu A, Kiryu S, Abe O . Deep learning with convolutional neural network in radiology. Jpn J Radiol. 2018; 36(4):257-272. DOI: 10.1007/s11604-018-0726-3. View

Aube C, Oberti F, Lonjon J, Pageaux G, Seror O, Nkontchou G . EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice. Liver Int. 2017; 37(10):1515-1525. DOI: 10.1111/liv.13429. View

Covey A, Hussain S . Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings. AJR Am J Roentgenol. 2017; 209(1):67-76. DOI: 10.2214/AJR.17.17799. View

Wang W, Zhu S, Ding Y, Yang L, Chen C, Ye Q . T mapping on gadoxetic acid-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy. Eur J Radiol. 2018; 103:25-31. DOI: 10.1016/j.ejrad.2018.03.027. View

Jiang T, Zhu A, Sahani D . Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma. J Hepatol. 2012; 58(1):169-77. DOI: 10.1016/j.jhep.2012.08.022. View

Marquez H, Puippe G, Mathew R, Alkadhi H, Pfammatter T, Fischer M . CT Perfusion for Early Response Evaluation of Radiofrequency Ablation of Focal Liver Lesions: First Experience. Cardiovasc Intervent Radiol. 2016; 40(1):90-98. DOI: 10.1007/s00270-016-1444-9. View

Chen C, Chen J, Xia C, Huang Z, Song B . T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma. J Biol Regul Homeost Agents. 2017; 31(4):1029-1036. View

10.

Li X, Li C, Wang R, Ren J, Yang J, Zhang Y . Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis. PLoS One. 2015; 10(12):e0144247. PMC: 4668097. DOI: 10.1371/journal.pone.0144247. View

11.

Wei C, Tan J, Xu L, Juan L, Zhang S, Wang L . Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis. Tumour Biol. 2014; 36(2):983-90. DOI: 10.1007/s13277-014-2663-9. View

12.

Ippolito D, Querques G, Okolicsanyi S, Talei Franzesi C, Strazzabosco M, Sironi S . Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study. Eur J Radiol. 2017; 90:34-41. DOI: 10.1016/j.ejrad.2017.02.027. View

13.

Lee S, Lee J, Kim K, Klotz E, Kim S, Lee J . Dual-energy computed tomography to assess tumor response to hepatic radiofrequency ablation: potential diagnostic value of virtual noncontrast images and iodine maps. Invest Radiol. 2010; 46(2):77-84. DOI: 10.1097/RLI.0b013e3181f23fcd. View

14.

Tang A, Hallouch O, Chernyak V, Kamaya A, Sirlin C . Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radiol (NY). 2017; 43(1):13-25. DOI: 10.1007/s00261-017-1209-1. View

15.

Marin D, Ramirez-Giraldo J, Gupta S, Fu W, Stinnett S, Mileto A . Effect of a Noise-Optimized Second-Generation Monoenergetic Algorithm on Image Noise and Conspicuity of Hypervascular Liver Tumors: An In Vitro and In Vivo Study. AJR Am J Roentgenol. 2016; 206(6):1222-32. DOI: 10.2214/AJR.15.15512. View

16.

Hatzidakis A, Perisinakis K, Kalarakis G, Papadakis A, Savva E, Ippolito D . Perfusion-CT analysis for assessment of hepatocellular carcinoma lesions: diagnostic value of different perfusion maps. Acta Radiol. 2018; 60(5):561-568. DOI: 10.1177/0284185118791200. View

17.

Ippolito D, Querques G, Pecorelli A, Talei Franzesi C, Okolicsanyi S, Strazzabosco M . Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients With Advanced Hepatocellular Carcinoma. J Comput Assist Tomogr. 2018; 43(2):206-213. DOI: 10.1097/RCT.0000000000000807. View

18.

Kim K, Choi S, Kim M, Baek S, Park S, Yoo K . The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization. J Vasc Interv Radiol. 2019; 30(3):358-369. DOI: 10.1016/j.jvir.2018.10.002. View

19.

Mule S, Thiefin G, Costentin C, Durot C, Rahmouni A, Luciani A . Advanced Hepatocellular Carcinoma: Pretreatment Contrast-enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated with Sorafenib. Radiology. 2018; 288(2):445-455. DOI: 10.1148/radiol.2018171320. View

20.

Gordic S, Bou Ayache J, Kennedy P, Besa C, Wagner M, Bane O . Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy. Abdom Radiol (NY). 2017; 42(6):1685-1694. PMC: 5590631. DOI: 10.1007/s00261-017-1066-y. View